|
MesalamineDrug - Mesalamine The trade name of the product as shown on the labeling.
Dosage -
ENEMA; RECTAL
Active Ingredient(s) -
Mesalamine
Strength -
4GM/60ML
Applicant -
TEVA
New Drug Application (NDA) Number -
076841
Product Number -
001
Therapeutic Equivalence (TE) Code -
AB
Approval Date -
Sep 30, 2004
Reference Listed Drug (RLD) -
No
Type -
RX
Applicant Full Name -
Teva Pharmaceuticals Usa Inc
Mesalamine
Pentasa 250mg Capsule, Extended Release; Oral
Pentasa 500mg Capsule, Extended Release; Oral Mesalamine 4gm/60ml Enema; Rectal Mesalamine 4gm/60ml Enema; Rectal Mercaptopurine 50mg Tablet; Oral Purinethol 50mg Tablet; Oral Mercaptopurine 50mg Tablet; Oral Merrem I.V. 1gm/vial Injectable; Injection Merrem I.V. 500mg/vial Injectable; Injection Mersalyl-theophylline 100mg/ml;50mg/ml Injectable; Injection NewDrugInformation |